110 related articles for article (PubMed ID: 6139390)
1. Medroxalol combined with hydrochlorothiazide in the treatment of hypertension.
Vlachakis ND; Valasquez M; Alexander N; Maronde RF
J Clin Pharmacol; 1983 Oct; 23(10):419-27. PubMed ID: 6139390
[TBL] [Abstract][Full Text] [Related]
2. Treatment of mild and moderate hypertension with medroxalol, an alpha- and beta-adrenergic antagonist.
Schechter PJ; Tanskanen A; Tuomilehto J; Koch-Weser J
J Cardiovasc Pharmacol; 1982; 4(6):955-9. PubMed ID: 6185788
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic effect of lofexidine with a diuretic in hypertension.
Vlachakis ND; Velasquez M; Alexander N; Maronde RF
Clin Pharmacol Ther; 1983 Dec; 34(6):764-9. PubMed ID: 6357591
[TBL] [Abstract][Full Text] [Related]
4. Acute effects of prizidilol on blood pressure, heart rate, catecholamines, renin and aldosterone in essential hypertension.
Bianchetti MG; Boehringer K; Weidmann P; Link L; Schiffl H; Ziegler WH
Eur J Clin Pharmacol; 1982 Oct; 23(4):289-96. PubMed ID: 6129141
[TBL] [Abstract][Full Text] [Related]
5. Alpha- and beta-adrenergic receptor blocking agents combined with a diuretic in the treatment of essential hypertension.
Vlachakis ND; Mendlowitz M
J Clin Pharmacol; 1976 Jul; 16(7):352-60. PubMed ID: 7576
[TBL] [Abstract][Full Text] [Related]
6. Reduction of left ventricular hypertrophy after longterm antihypertensive treatment with doxazosin.
Agabiti-Rosei E; Muiesan ML; Rizzoni D; Zulli R; Calebich S; Beschi M; Castellano M; Muiesan G
J Hum Hypertens; 1992 Feb; 6(1):9-15. PubMed ID: 1349920
[TBL] [Abstract][Full Text] [Related]
7. Effects of timolol and hydrochlorothiazide on blood-pressure and plasma renin activity. Double-blind factorial trial.
Chalmers J; Tiller D; Horvath J; Bune A
Lancet; 1976 Aug; 2(7981):328-31. PubMed ID: 60566
[TBL] [Abstract][Full Text] [Related]
8. Bucindolol, a beta-adrenoceptor blocker with vasodilatory action: its effect in systemic hypertension.
Rotmensch HH; Rocci ML; Vlasses PH; Swanson BN; Fedder IL; Soyka L; Ferguson RK
Am J Cardiol; 1984 Aug; 54(3):353-6. PubMed ID: 6147080
[TBL] [Abstract][Full Text] [Related]
9. The combined alpha- and beta-adrenergic blocker labetalol and propranolol in the treatment of high blood pressure: similarities and differences.
Weber MA; Drayer JI; Kaufman CA
J Clin Pharmacol; 1984; 24(2-3):103-12. PubMed ID: 6143765
[TBL] [Abstract][Full Text] [Related]
10. Diuretics, beta-blockers or both as treatment for essential hypertension.
Stumpe KO; Overlack O
Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):189S-197S. PubMed ID: 37874
[TBL] [Abstract][Full Text] [Related]
11. Step II treatment with labetalol for essential hypertension.
Bloomfield SS; Lucas CP; Gantt CL; Poland MP; Medakovic M
Am J Med; 1983 Oct; 75(4A):81-6. PubMed ID: 6356902
[TBL] [Abstract][Full Text] [Related]
12. Effects of medroxalol on renal function and the renin-angiotensin-aldosterone axis.
Wallin JD; Jones P; O'Neill WM; Kuzma RJ; Morgan RJ; Morgan M; Rolf C
Clin Pharmacol Ther; 1984 Aug; 36(2):169-73. PubMed ID: 6146422
[TBL] [Abstract][Full Text] [Related]
13. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
Prichard BN
Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular properties of medroxalol, a new antihypertensive drug.
Dage RC; Cheng HC; Woodward JK
J Cardiovasc Pharmacol; 1981; 3(2):299-315. PubMed ID: 6166802
[TBL] [Abstract][Full Text] [Related]
15. [Effects of combined treatment with hydrochlorothiazide and oxprenolol on arterial pressure and activity of plasma renin. Preliminary results].
Gysling E; de Wurstemberger B
Schweiz Med Wochenschr; 1974 Dec; 104(49):1797-8. PubMed ID: 4456598
[No Abstract] [Full Text] [Related]
16. Felodipine versus hydrochlorothiazide as an addition to a beta-blocker in the treatment of hypertension.
Borgmästars H; Forsén B; Tuomilehto J; Hellebø R; Walle PO; Nielsen HM; Nielsen E; Winkel O; Steiness E; Ibsen H
Drugs; 1987; 34 Suppl 3():136-8. PubMed ID: 2894972
[No Abstract] [Full Text] [Related]
17. Beta-blockers in the management of hypertension: focus on nebivolol.
Wojciechowski D; Papademetriou V
Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):471-9. PubMed ID: 18402537
[TBL] [Abstract][Full Text] [Related]
18. Catecholamines and the renin-angiotensin-aldosterone system during treatment with felodipine ER or hydrochlorothiazide in essential hypertension.
Koenig W; Binner L; Gabrielsen F; Sund M; Rosenthal J; Hombach V
J Cardiovasc Pharmacol; 1991 Sep; 18(3):349-53. PubMed ID: 1720834
[TBL] [Abstract][Full Text] [Related]
19. Bevantolol attenuates thiazide stimulated renin secretion and catecholamine release in diuretic resistant hypertensives.
Fernandez PG; Snedden W; Vasdev S; Bolli P
Can J Cardiol; 1989 Mar; 5(2):93-7. PubMed ID: 2565158
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of the antihypertensive effect of hydrochlorothiazide in dogs after suppression of renin release by beta-adrenergic blockade.
Sweet CS; Mandradjieff M
Clin Sci Mol Med; 1975 Feb; 48(2):147-51. PubMed ID: 234821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
